Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists

被引:13
|
作者
Dzierba, CD [1 ]
Takvorian, AG [1 ]
Rafalski, M [1 ]
Kasireddy-Polam, P [1 ]
Wong, H [1 ]
Molski, TF [1 ]
Zhang, G [1 ]
Li, YW [1 ]
Lelas, S [1 ]
Peng, Y [1 ]
McElroy, JF [1 ]
Zaczek, RC [1 ]
Taub, RA [1 ]
Combs, AP [1 ]
Gilligan, PJ [1 ]
Trainor, GL [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
关键词
D O I
10.1021/jm049737f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Corticotropin releasing factor (CRF) is the primary regulator of the hypothalamus-pituitary-adrenal (HPA) axis, coordinating the endocrine, behavioral, and autonomic responses to stress. It has been postulated that small molecules that can antagonize the binding of CRF, to its receptor may serve as a treatment for anxiety-related and/or affective disorders. Members within a series of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones, exemplified by compound 2 (IC50 = 0.70 nM), were found to be very potent antagonists of CRF1. Compound 8w showed high CRF1 receptor binding affinity and was examined further in vivo. The compound was efficacious in a defensive withdrawal model of anxiety in rats and had a long half-life and reasonable oral bioavailability in dog pharmacokinetic studies.
引用
收藏
页码:5783 / 5790
页数:8
相关论文
共 50 条
  • [31] Synthesis of 1-alkyl-3-dialkylaminoalkylamine[1]benzothieno[2,3-b]pyrazin-2(1H)-ones and their ability to antagonize KCl-induced contractions
    Guerrera, F
    Salerno, L
    Sarva, MC
    Siracusa, MA
    Rescifina, A
    Scalia, R
    Bianchi, A
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (7-8) : 607 - 613
  • [32] Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor
    Aso, Kazuyoshi
    Kobayashi, Katsumi
    Mochizuki, Michiyo
    Kanzaki, Naoyuki
    Sako, Yuu
    Yano, Takahiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2365 - 2371
  • [33] Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor
    Aso, Kazuyoshi
    Kobayashi, Katsumi
    Mochizuki, Michiyo
    Kanzaki, Naoyuki
    Sako, Yuu
    Yano, Takahiko
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [34] Synthesis and structure-affinity relationships of 4-(5-aryl-1,2,3,6-tetrahydropyridino)pyrimidine derivatives as corticotropin-releasing factor1 receptor antagonists
    Kumagai, T
    Okubo, T
    Kataoka-Okubo, H
    Chaki, S
    Okuyama, S
    Nakazato, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (05) : 1349 - 1355
  • [35] SYNTHESIS AND PROPERTIES OF SOME NEW 11-ACYL-5,11-DIHYDRO-6H-PYRIDO[2,3-B] [1,4]-BENZODIAZEPIN-6-ONES
    DECORTE, E
    GRATTON, G
    KOVAC, T
    MIHALIC, M
    COMISSO, G
    ANGELI, C
    TOSO, R
    SUNJIC, V
    FARMACO-EDIZIONE SCIENTIFICA, 1982, 37 (12): : 787 - 796
  • [36] A Facile Synthesis and Antitumor Activity of Novel 2-Aryl-2,3-dihydro-1H-pyrrolo[3,4-b]quinoxalin-1-ones
    Xi, Qian
    Jiang, Wenting
    Wang, Hongxue
    Liu, Jia
    Sun, Fuze
    Wen, Baohan
    Zhao, Xinyue
    Gao, Siyang
    Li, Yang
    POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42 (07) : 4066 - 4077
  • [37] Synthesis, biological activity and quantitative structure-activity relationships of N-substituted-3,4-dihydro-2H-1-benzopyran derivatives
    Marot, C
    Comoy, C
    Viaud, MC
    Rettori, MC
    Pfeiffer, B
    MorinAllory, L
    Guillaumet, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (10) : 1077 - 1082
  • [38] Synthesis and structure-activity relationships of 2-(1,4′-bipiperidin-1′-yl)thiazolopyridine as H3 receptor antagonists
    Rao, Ashwin U.
    Palani, Anandan
    Chen, Xiao
    Huang, Ying
    Aslanian, Robert G.
    West, Robert E., Jr.
    Williams, Shirley M.
    Wu, Ren-Long
    Hwa, Joyce
    Sondey, Christopher
    Lachowicz, Jean
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6176 - 6180
  • [39] Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase
    Milkiewicz, Karen L.
    Weinberg, Linda R.
    Albom, Mark S.
    Angeles, Thelma S.
    Cheng, Mangeng
    Ghose, Arup K.
    Roemmele, Renee C.
    Theroff, Jay P.
    Underiner, Ted L.
    Zificsak, Craig A.
    Dorsey, Bruce D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (12) : 4351 - 4362
  • [40] NOVEL SYNTHESIS OF 5,11-DIHYDRO-6H-PYRIDO[2,3-B]-[1,4]BENZODIAZEPIN-6-ONES AND RELATED STUDIES .1.
    OKLOBDZIJA, M
    COMISSO, G
    DECORTE, E
    FAJDIGA, T
    GRATTON, G
    MOIMAS, F
    TOSO, R
    SUNJIC, V
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1983, 20 (05) : 1329 - 1334